GL1X · GenesisL1 explorer

UniProt Q16602

Calcitonin gene-related peptide type 1 receptor (Q16602)

Calcitonin gene-related peptide type 1 receptor (UniProt Q16602): 34 experimental structures and 1 predicted model on GenesisL1, 9 ligands bound, 63 pockets. Binding sites, druggability and experiment against prediction…

UniProt
Q16602
Protein
Calcitonin gene-related peptide type 1 receptor
Experimental structures
34
Predicted models
1
Ligands
9
Pockets
63 · 8 records with a druggable one

Structures

35 records of Q16602 in the MolNFT archive: 34 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
3AQFCrystal structure of the human CRLR/RAMP2 extracellular complexx-ray diffractionB——
3AQFCrystal structure of the human CRLR/RAMP2 extracellular complexx-ray diffractionB——
3N7PCrystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site…x-ray diffractionA, B, C, J——
3N7PCrystal structure of the ectodomain complex of the cgrp receptor, a class-B GPCR, reveals the site…x-ray diffractionA, B, C, J——
3N7RCrystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site…x-ray diffractionA, B——
3N7RCrystal structure of the ectodomain complex of the cgrp receptor, a class-B GPCR, reveals the site…x-ray diffractionA, B——
3N7SCrystal structure of the ectodomain complex of the CGRP receptor, a Class-B GPCR, reveals the site…x-ray diffractionA, B——
3N7SCrystal structure of the ectodomain complex of the cgrp receptor, a class-B GPCR, reveals the site…x-ray diffractionA, B——
4RWFCrystal structure of the CLR:RAMP2 extracellular domain heterodimer with bound adrenomedullinx-ray diffractionA——
4RWFCrystal structure of the CLR:RAMP2 extracellular domain heterodimer with bound adrenomedullinx-ray diffractionA——
4RWGCrystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity CGRP…x-ray diffractionA, B, C——
4RWGCrystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity cgrp…x-ray diffractionA, B, C——
5V6YCrystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity…x-ray diffractionA, B, C, DGLC20 (best 0.81)
5V6YCrystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity…x-ray diffractionA, B, C, DNH2, GLC—
6D1UCrystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with…x-ray diffractionA, B, CNH2, GLC, NA—
6E3YCryo-EM structure of the active, Gs-protein complexed, human CGRP receptorelectron microscopyR—7 (best 0.76)
6E3YCryo-EM structure of the active, gs-protein complexed, human cgrp receptorelectron microscopyRNH2—
6UMGCrystal structure of erenumab Fab bound to the extracellular domain of CGRP receptorx-ray diffractionC, c—8 (best 0.63)
6UMGCrystal structure of erenumab Fab bound to the extracellular domain of cgrp receptorx-ray diffractionC, c——
6UUNCryoem structure of the active adrenomedullin 1 receptor G protein complex with adrenomedullin…electron microscopyR——
6UUSCryoem structure of the active adrenomedullin 2 receptor G protein complex with adrenomedullin…electron microscopyR——
6UVACryoem structure of the active adrenomedullin 2 receptor G protein complex with adrenomedullin 2…electron microscopyR——
6V2ECrystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity…x-ray diffractionAGLC, NH2—
6ZHOCrystal structure of a cgrp receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, QLQ—
6ZISCrystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, 3N67 (best 0.82)
6ZISCrystal structure of a cgrp receptor ectodomain heterodimer with bound high affinity inhibitorx-ray diffractionAGLC, 3N6—
7KNTCryoEM structure of the apo-CGRP receptor in a detergent micelleelectron microscopyR—4 (best 0.70)
7KNTCryoem structure of the apo-cgrp receptor in a detergent micelleelectron microscopyR——
7KNUCryoem structure of the cgrp receptor with bound cgrp peptide in a detergent micelleelectron microscopyR——
7P0FCrystal structure of a cgrp receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, 7IR—
7P0ICrystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor Compound…x-ray diffractionAGLC, 7IU6 (best 0.83)
7P0ICrystal structure of a cgrp receptor ectodomain heterodimer bound to macrocyclic inhibitor compound…x-ray diffractionAGLC, 7IU—
8AX5Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, OKU7 (best 0.84)
8AX6Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor…x-ray diffractionAGLC, OP94 (best 0.85)
Q16602AlphaFold monomer V2.0 prediction for calcitonin gene-related peptide type 1 receptor (Q16602)predictedA——

Ligands

  • GLC · alpha-D-glucopyranose · in 12 records
  • NH2 · Amino group · in 4 records
  • 3N6 · N-{(1S)-5-amino-1-[(4-pyridin-4-ylpiperazin-1-yl) carbonyl]pentyl}-3,5-dibromo-nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3 (2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide · in 2 records
  • 7IU · (1S,20E)-10-(benzofuran-3-ylmethyl)-12-methyl-15,18-dioxa-5,9,12,24,26-pentazapentacyclo[20.5.2.11,4.13, 7.025,28]hentriaconta-3(30),4,6,20,22(29),23,25(28)-heptaene-8,11,27-trione · in 2 records
  • 7IR · (1S,10R,23E)-12-methyl-10-[(7-methyl-1H-indazol-5-yl) methyl]-15,18,21-trioxa-5,9,12,27,29-pentazapentacyclo[23.5.2.11,4.13,7.028, 31]tetratriaconta-3(33),4,6,23,25(32),26,28(31)-heptaene-8,11,30-trione · in 1 record
  • NA · Sodium ion · in 1 record
  • OKU · (1~{R},10~{R},20~{E})-12-methyl-10-[(7-methyl-2~{H}-indazol-5-yl)methyl]-15,18-dioxa-9,12,24,26-tetrazapentacyclo[20.5.2.1^{1,4}.1^{3,7}.0^{25,28}]hentriaconta-3,5,7(30),20,22,24,28-heptaene-8,11,27-trione · in 1 record
  • OP9 · (1~{S},10~{R},20~{E})-12-methyl-10-[(7-methyl-2~{H}-indazol-5-yl)methyl]-15,18-dioxa-9,12,24,26-tetrazapentacyclo[20.5.2.1^{1,4}.1^{3,7}.0^{25,28}]hentriaconta-3(30),4,6,20,22,24,28-heptaene-8,11,27-trione · in 1 record
  • QLQ · ~{N}-[(2~{R})-3-(7-methyl-2~{H}-indazol-5-yl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-piperidin-4-yl-1-(4-pyridin-4-ylpiperazin-1-yl)propan-2-yl]amino]propan-2-yl]-2-oxidanylidene-spiro[1~{h}-pyrido[2,3-d][1,3]oxazine-4,4'-piperidine]-1'-carboxamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.